Trial
NCT05442346
Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells
UnknownSUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Bioray Laboratories
Collaborators
First Affiliated Hospital of Guangxi Medical University
Condition
Thalassemia Major
Intervention
γ-globin reactivated autologous hematopoietic stem cells
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-28